• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bioniq Secures $15M to Expand AI-Driven Personalized Supplements Globally

by Jasmine Pennic 07/16/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Bioniq, the leading provider of personalized supplements based on blood biomarker data, raises $15M Series B funding led by prominent European venture capitalists HV Capital and Unbound, reaching a valuation of $75M. 

– The fresh capital will be used to propel Bioniq’s global market dominance and disrupt the traditional dietary supplements industry.

Personalized Supplements Driving Growth

Bioniq’s data-driven approach to personalized health solutions has seen impressive growth, particularly in the United States. The US market now comprises over half of Bioniq’s customer base, with some regions experiencing a staggering 500% surge in the past six months.

A key driver of Bioniq’s success is its ability to provide users with quantifiable results. Bioniq’s “before-and-after” snapshots of users’ nutrient needs and progress resonate with leading health and sports institutions like Lanserhof and UFC. This has positioned Bioniq as the supplement of choice for elite athletes, including Manchester United’s Diogo Dalot and former NBA All-Star Andrei Kirilenko, who rely on Bioniq to optimize their micronutrient levels and enhance performance and recovery.

Tailored Solutions for Individual Needs

Bioniq leverages over a decade of expertise to house the largest proprietary biochemical database in the industry. This data pool, alongside blood test information from customers worldwide, fuels Bioniq’s AI-powered algorithm. The algorithm analyzes an individual’s unique data points, including height, weight, age, lifestyle, and health goals, to pinpoint micronutrient imbalances and create a personalized supplement formula for optimal health.

Bioniq PRO: Hyper-Personalization with Blood Biomarker Data

The Bioniq PRO program caters to high performers and health enthusiasts seeking the ultimate level of personalization. This program integrates blood biomarker data into its algorithm. Users can either upload existing bloodwork or schedule a test through a Bioniq partner lab. The blood data is then meticulously analyzed to assess current nutrient status, identify deficiencies, and recommend a personalized daily supplement formula. Additionally, Bioniq PRO offers 1:1 consultations with registered dietitians to address individual needs and chart a personalized health journey.

Bioniq GO: Making Personalized Wellness More Accessible

Bioniq GO offers a more accessible entry point for users seeking personalized wellness solutions. This program utilizes Bioniq’s vast database and leverages a user questionnaire to guide the AI algorithm. Based on responses and anonymized blood biomarker data from previous users, the algorithm recommends a unique supplement blend tailored to the individual’s needs.

Quality and Innovation at the Core

Bioniq prioritizes quality and innovation. All Bioniq supplements are Swiss-made, pharmaceutical-grade, and utilize precise micro-dosing to address individual needs and deficiencies. Each formula is unique and features a customized blend of antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fiber. Bioniq ditches traditional pills and capsules, opting for patented prebiotic guar granules that mimic the body’s natural digestion process, minimizing nutrient competition and maximizing bioavailability.

“We’ve entered a new era in nutritional supplementation over the last six years, where it’s become clear that one-size-fits-all solutions are simply inefficient,” said Vadim Fedotov, co-founder and CEO of Bioniq. “Everyone’s health journey is unique and fluid. Customers need advanced, adaptable products that provide evolving support for personal health goals. Our AI-driven approach and extensive biochemical database allow us to create customized supplements that provide quantifiable results and cater to individuals’ specific needs. Beyond meeting consumer demand, we’re setting a new standard in the industry by making the process and results transparent to the users.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |